Skip to main content
Livermore
Livermore
ZHEN

Ovid Therapeutics Inc.

OVID
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001636651

No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Ovid Therapeutics Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
82
+1 vs. Q4 2024
Shares held
46.4M
−1.05M (−2.2%) vs. Q4 2024
Total value
$14.5M
−$29.8M (−67.3%) vs. Q4 2024
New holders
10
20 more added
Sold out
9
28 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting OVID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 82 institutions
Q1 2021: 88 institutionsQ2 2021: 80 institutionsQ3 2021: 72 institutionsQ4 2021: 67 institutionsQ1 2022: 62 institutionsQ2 2022: 55 institutionsQ3 2022: 59 institutionsQ4 2022: 60 institutionsQ1 2023: 61 institutionsQ2 2023: 69 institutionsQ3 2023: 64 institutionsQ4 2023: 77 institutionsQ1 2024: 81 institutionsQ2 2024: 74 institutionsQ3 2024: 75 institutionsQ4 2024: 82 institutionsQ1 2025: 82 institutionsQ2 2025: 71 institutionsQ3 2025: 81 institutionsQ4 2025: 84 institutionsQ1 2026: 103 institutionsQ2 2026: 130 institutions
Value heldQ1 2025: $14.5M
Q1 2021: $145.7MQ2 2021: $130.5MQ3 2021: $112.9MQ4 2021: $109.2MQ1 2022: $110.3MQ2 2022: $74.5MQ3 2022: $65.5MQ4 2022: $71.7MQ1 2023: $99.8MQ2 2023: $134.5MQ3 2023: $162.6MQ4 2023: $166.3MQ1 2024: $152.8MQ2 2024: $35.4MQ3 2024: $54.7MQ4 2024: $44.4MQ1 2025: $14.5MQ2 2025: $11.9MQ3 2025: $47.1MQ4 2025: $100.2MQ1 2026: $233.2MQ2 2026: $395.5M
Institutions holding OVID and their total value by quarter
QuarterHoldersValue
Q2 2026130$395.5M
Q1 2026103$233.2M
Q4 202584$100.2M
Q3 202581$47.1M
Q2 202571$11.9M
Q1 202582$14.5M
Q4 202482$44.4M
Q3 202475$54.7M
Q2 202474$35.4M
Q1 202481$152.8M
Q4 202377$166.3M
Q3 202364$162.6M
Q2 202369$134.5M
Q1 202361$99.8M
Q4 202260$71.7M
Q3 202259$65.5M
Q2 202255$74.5M
Q1 202262$110.3M
Q4 202167$109.2M
Q3 202172$112.9M
Q2 202180$130.5M
Q1 202188$145.7M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Ovid Therapeutics Inc.; share changes are against Q4 2024.

Institutions holding OVID in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
CWM, LLC1,449$00.00%−91−5.9%Reduced
Advisor Group Holdings, Inc.5$10.00%−285−98.3%Reduced
GWM Advisors LLC4$10.00%+4New
The PNC Financial Services Group, Inc.6$20.00%−255−97.7%Reduced
IFP Advisors, Inc8$20.00%00.0%Unchanged
Sound Income Strategies, LLC6$20.00%00.0%Unchanged
Frazier Financial Advisors, LLC10$40.00%00.0%Unchanged
EverSource Wealth Advisors, LLC17$50.00%−4−19.0%Reduced
TD Waterhouse Canada Inc.30$90.00%00.0%Unchanged
True Wealth Design, LLC32$100.00%+32New
Sterling Capital Management LLC61$190.00%00.0%Unchanged
Nisa Investment Advisors, LLC400$1250.00%−1,673−80.7%Reduced
SBI Securities Co., Ltd.884$2760.00%+800+952.4%Added
Sandy Spring Bank2,300$7180.00%00.0%Unchanged
Amalgamated Bank2,011$1.00K0.00%00.0%Unchanged
Royal Bank of Canada5,774$1.00K0.00%+4,077+240.2%Added
California State Teachers Retirement System4,267$1.33K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.4,924$1.54K0.00%00.0%Unchanged
Legal & General Group Plc6,579$2.05K0.00%00.0%Unchanged
Abel Hall, LLC10,238$3.19K0.00%+10,238New
Dimensional Fund Advisors LP10,719$3.34K0.00%−82,252−88.5%Reduced
ProShare Advisors LLC12,754$3.98K0.00%−3,830−23.1%Reduced
CIBC World Markets Corp13,068$4.08K0.00%+13,068New
AQR Capital Management LLC15,450$4.82K0.00%+4,811+45.2%Added
Los Angeles Capital Management LLC15,681$4.89K0.00%+15,681New
Newman Dignan & Sheerar, Inc.16,522$5.15K0.00%00.0%Unchanged
New York State Common Retirement Fund18,986$5.92K0.00%00.0%Unchanged
Price T Rowe Associates Inc17,396$6.00K0.00%00.0%Unchanged
HRT Financial LP25,592$7.00K0.00%+25,592New
Blair William & Co23,039$7.19K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)23,846$7.44K0.00%+14,006+142.3%Added
First Manhattan Co26,000$8.11K0.00%00.0%Unchanged
UBS Group AG26,958$8.41K0.00%−33,809−55.6%Reduced
Invesco Ltd.27,207$8.49K0.00%00.0%Unchanged
Corebridge Financial, Inc.28,852$9.00K0.00%−427−1.5%Reduced
FMR LLC30,897$9.64K0.00%−4,019−11.5%Reduced
Bank of America Corp31,750$9.87K0.00%−24,983−44.0%Reduced
Mirae Asset Global ETFs Holdings Ltd.37,012$11.5K0.00%+1,482+4.2%Added
SG Americas Securities, LLC43,028$13.0K0.00%+5,392+14.3%Added
Citigroup Inc43,197$13.5K0.00%−5,354−11.0%Reduced
Intech Investment Management LLC44,010$13.7K0.00%+20,286+85.5%Added
Alliancebernstein L.P.47,780$14.9K0.00%00.0%Unchanged
Barclays PLC63,918$19.9K0.00%−29,389−31.5%Reduced
BNP Paribas Arbitrage, SA66,953$20.9K0.00%−37,759−36.1%Reduced
Rhumbline Advisers80,917$25.2K0.00%−3,161−3.8%Reduced
Morgan Stanley82,727$25.8K0.00%−106,760−56.3%Reduced
Susquehanna International Group, LLP83,084$25.9K0.00%+37,964+84.1%Added
Empowered Funds, LLC91,234$28.5K0.00%−47,181−34.1%Reduced
XTX Topco Ltd93,154$29.1K0.00%+93,154New
Bridgeway Capital Management, LLC95,434$29.8K0.00%−133,681−58.3%Reduced
Velan Capital Investment Management LP97,000$30.3K0.03%+27,000+38.6%Added
Goldman Sachs Group Inc104,435$32.6K0.00%−93,688−47.3%Reduced
Deutsche Bank AG105,177$32.6K0.00%00.0%Unchanged
ADAR1 Capital Management, LLC115,867$36.1K0.01%−14,665−11.2%Reduced
Nuveen, LLC119,113$37.2K0.00%+119,113New
Charles Schwab Investment Management Inc135,487$42.3K0.00%−26,321−16.3%Reduced
Bank of New York Mellon Corp165,763$51.7K0.00%00.0%Unchanged
Jacobs Levy Equity Management, Inc200,593$62.6K0.00%−91,108−31.2%Reduced
Verition Fund Management LLC215,060$67.1K0.00%+67,755+46.0%Added
Squarepoint Ops LLC265,491$82.8K0.00%+265,491New
Citadel Advisors LLC367,974$114.8K0.00%+360,517+4,834.6%Added
Northern Trust Corp423,618$132.1K0.00%−64,553−13.2%Reduced
Gsa Capital Partners LLP440,103$137.0K0.01%+316,520+256.1%Added
Assenagon Asset Management S.A.560,830$174.9K0.00%+490,716+699.9%Added
Affinity Asset Advisors, LLC667,516$208.2K0.03%+667,516New
TLS Advisors LLC680,967$213.0K0.48%00.0%Unchanged
Wells Fargo & Company786,547$245.3K0.00%+42,740+5.7%Added
Renaissance Technologies LLC1,023,800$319.3K0.00%+916,100+850.6%Added
Adage Capital Partners GP, L.L.C.1,150,000$358.7K0.00%+150,000+15.0%Added
JPMorgan Chase & Co1,208,624$377.0K0.00%−209,682−14.8%Reduced
Geode Capital Management, LLC1,330,993$415.2K0.00%+1,558+0.1%Added
State Street Corp1,372,108$428.0K0.00%−22,410−1.6%Reduced
Driehaus Capital Management LLC1,400,191$436.7K0.00%00.0%Unchanged
Kennedy Capital Management, Inc.1,732,865$540.5K0.01%+187,478+12.1%Added
Acadian Asset Management LLC2,088,046$650.0K0.00%+237,445+12.8%Added
Sio Capital Management, LLC2,232,000$696.2K0.21%+1,232,000+123.2%Added
Madison Avenue Partners, LP2,465,623$769.0K0.07%−1,257,004−33.8%Reduced
Vanguard Group Inc3,108,781$969.9K0.00%−39,301−1.2%Reduced
BVF Inc3,853,818$1.20M0.05%00.0%Unchanged
BlackRock, Inc.3,859,582$1.20M0.00%−69,002−1.8%Reduced
Rubric Capital Management LP5,315,969$1.66M0.03%00.0%Unchanged
Takeda Pharmaceutical Co Ltd7,531,996$2.35M14.51%00.0%Unchanged
Siren, L.L.C.0$00.00%−2,850,000−100.0%Sold out
UBS Oconnor LLC0$00.00%−943,416−100.0%Sold out
Monimus Capital Management, LP0$00.00%−138,266−100.0%Sold out
Jane Street Group, LLC0$00.00%−14,278−100.0%Sold out
BBR Partners, LLC0$00.00%−12,495−100.0%Sold out
DCF Advisers, LLC0$00.00%−11,750−100.0%Sold out
Capital Advisors, Ltd. LLC0$00.00%−1,710−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−447−100.0%Sold out
Simplex Trading, LLC0$00.00%−590−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed